Enzolytics (ENZC) Stock Attempts To Recovery: Will The Rally Continue?

In the past two weeks, the Enzolytics Inc (OTCMKTS:ENZC) stock has been on...

Stay Ahead of the
Stock Market Game!
Subscribe to Small Cap
Exclusive for more


Stern Ricky is Buying Asta Funding Inc. (NASDAQ:ASFI...
3 Momentum Stocks: Avenue Therapeutics (ATXI), Pasit...
Here's Who Just Picked Up Depomed Inc. (NASDAQ:DEPO)...

In the past two weeks, the Enzolytics Inc (OTCMKTS:ENZC) stock has been on the radars of many investors and that becomes far more apparent from the price action in the stock. The stock has recorded gains of 35% during that period and the rally continued on Tuesday.

Yesterday, it jumped by as much as 15.5% and in this sort of situation; it might be a good idea for investors to take a closer look at the company. One of the more important positive triggers for the stock came about on May 26 when the company announced that it had managed to identify immutable sites on the HTLV-1 virus.

It is a major development since it is going to help Enzolytics in its work to product monoclonal antibodies that are supposed to work against the HTLV-1 virus. In this regard, investors need to keep in mind that at this point there are no effective vaccines in the market that can actually tackle the HTVL-1 virus.

While this discovery was an important factor behind the rally in the Enzolytics stock, it is important to mention that there were some other important developments as well. In the middle of May, it was announced that Enzolytics collaborated with Intel Corporation to publish a white paper.

The white paper, titled “Optimizing Empathetic A.I. to Cure Deadly Diseases”, pointed out that the innovative approach of Enzolytics and the artificial intelligence analytics tools of Intel could be combined to produce effective treatments meant for all types of virus infections. This white argues that in the future the aim of healthcare is going to be more anticipatory than reactionary.

Back in April the company had also made an announcement with regards to the sort of progress it has made on a range of initiatives including the one related to its multiple therapeutics platform. It is now going to be interesting to see if the Enzolytics stock can maintain its momentum in the coming days.

Stay in the lopp :

Here's Who Just Picked Up Jpmorgan China Regi...
In a just published Form 13, filed with the US Securities and Exchange Commission (SEC), Jpmorgan China Region Fund Inc. (NYSE:JFC) reported that City Of
Advent Technologies Holdings ADN Stock Price ...

Advent Technologies Holdings ADN stock price is up 170% in the last 5 days, really just today it is up that

Atzmon Menachem Picked Icts International N V...
In a just published Form 13, filed with the US Securities and Exchange Commission (SEC), Icts International N V (OTCMKTS:ICTSF) reported that Atzmon Menachem has

related post

Skip to content